Profile

Ribonomics, Inc. is a Systems Biology company focused on the development of innovative products for the diagnosis and treatment of human diseases. Employing proprietary technologies developed at Duke University Medical Center, the Company empirically connects biological pathways to human disease. This capability represents a powerful solution for accelerating drug discovery.

The core of the Ribonomics Technology Platform is the ability to directly observe the cell's organizational mechanisms governing protein expression. This enables Ribonomics to directly observe pathways and networks leading to human disease and to extract novel therapeutic targets for treatment.